Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7355 p782
25 June 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
No Smoking links


Consultation opens on smoking ban in enclosed places

Smoking ban

Detail of smoking ban revealed this week

Proposals on how legislation banning smoking in enclosed places in England and Wales would work in practice were unveiled by public health minister, Caroline Flint, this week. Key stakeholders are being consulted on the details of a smoking ban, ahead of a Bill being introduced in the autumn.

Although the Bill will apply to England and Wales, the provisions described in detail in the consultation document only apply to England. The consultation proposes that the Bill should enable the Welsh Assembly Government to make its own provision for smoke-free public spaces.

Commenting on the content of the consultation, Miriam Armstrong, chief executive of PharmacyHealthLink, said that the danger of second-hand smoke is still being played down. “The Department of Health still appears to be treating the issue as an ‘optional extra’ instead of a health and safety issue. They are asking us to comment on which option we would prefer, as if their actions should be swayed by the popularity stakes,” she said. “Instead, most businesses, local authorities and the public health community have come out in favour of the easiest option to implement and enforce — which is a complete ban in enclosed areas.”

In addition, over 70 per cent of adults in Britain and 65 per cent of smokers believe that smoking should be banned in households with children, a survey of 1,275 adults has found. The survey was conducted on behalf of Developing Patient Partnerships, which this week launched a “Driving out smoking” campaign to encourage people to think about the impact of smoking in their home.

WHO support for Scottish Ban The Scottish Executive’s plan to ban smoking in enclosed public places received the support of the World Health Organization this week. According to Peter Boyle, director of WHO’s international agency for research on cancer: “The comprehensive approach proposed is completely in line with what WHO has been advocating for many years,” he said. He added: “It is a great example for other countries around the world to follow and, most importantly, will be of great benefit to the health of the Scottish population.”

Back to Top


©The Pharmaceutical Journal